Josh Gottheimer, Representative
sell disclosed on 29 Dec 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
er Edwards Lifesciences Corporation Common Stock (EW)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
13 disclosures
8 insiders
0 cluster signals
0.0% avg. 30d outcome
Company facts
- Ticker / ISIN
- EW / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Related insiders
Bruce Westerman
Representative, 2 disclosures
Daniel Goldman
Representative, 1 disclosure
Jefferson Shreve
Representative, 2 disclosures
John Curtis
Representative, 3 disclosures
Josh Gottheimer
Representative, 2 disclosures
Mike Kelly
Representative, 1 disclosure
Rob Bresnahan
Representative, 1 disclosure
Zoe Lofgren
Representative, 1 disclosure
Disclosure history
Jefferson Shreve, Representative
sell disclosed on 22 Jun 2025 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Bruce Westerman, Representative
sell disclosed on 12 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Jefferson Shreve, Representative
buy disclosed on 8 May 2025 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
buy disclosed on 8 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Bruce Westerman, Representative
buy disclosed on 16 Apr 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Mike Kelly, Representative
sell disclosed on 14 Jun 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
buy disclosed on 7 Jan 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John Curtis, Representative
sell disclosed on 15 Dec 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John Curtis, Representative
buy disclosed on 7 Aug 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Zoe Lofgren, Representative
sell disclosed on 6 Jun 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John Curtis, Representative
buy disclosed on 10 May 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Daniel Goldman, Representative
buy disclosed on 17 Apr 2023 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%